BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rudloff U, Jacks LM, Goldberg JI, Wynveen CA, Brogi E, Patil S, Van Zee KJ. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 2010;28:3762-9. [PMID: 20625132 DOI: 10.1200/JCO.2009.26.8847] [Cited by in Crossref: 221] [Cited by in F6Publishing: 75] [Article Influence: 18.4] [Reference Citation Analysis]
Number Citing Articles
1 Kaur H, Mao S, Shah S, Gorski DH, Krawetz SA, Sloane BF, Mattingly RR. Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ. Expert Rev Mol Diagn 2013;13:151-65. [PMID: 23477556 DOI: 10.1586/erm.13.4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
2 Merlino G, Miodini P, Paolini B, Carcangiu ML, Gennaro M, Dugo M, Daidone MG, Cappelletti V. Stromal Activation by Tumor Cells: An in Vitro Study in Breast Cancer. Microarrays (Basel) 2016;5:E10. [PMID: 27600076 DOI: 10.3390/microarrays5020010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Barrio AV, Van Zee KJ. Controversies in the Treatment of Ductal Carcinoma in Situ. Annu Rev Med 2017;68:197-211. [PMID: 28099081 DOI: 10.1146/annurev-med-050715-104920] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
4 Lagios MD. Duct carcinoma in situ: A personal perspective. Breast J 2020;26:1132-7. [PMID: 32390260 DOI: 10.1111/tbj.13860] [Reference Citation Analysis]
5 Vidali C, Caffo O, Aristei C, Bertoni F, Bonetta A, Guenzi M, Iotti C, Leonardi MC, Mussari S, Neri S, Pietta N. Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study. Radiat Oncol 2012;7:177. [PMID: 23098066 DOI: 10.1186/1748-717X-7-177] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lee RJ, Vallow LA, McLaughlin SA, Tzou KS, Hines SL, Peterson JL. Ductal carcinoma in situ of the breast. Int J Surg Oncol 2012;2012:123549. [PMID: 22852075 DOI: 10.1155/2012/123549] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
7 Notake T, Kobayashi A, Shinkawa H, Kawahara T, Shimizu A, Yokoyama T, Hasegawa K, Kokudo N, Matsuyama Y, Makuuchi M, Miyagawa SI. Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection. Int J Clin Oncol 2017;22:715-25. [PMID: 28303401 DOI: 10.1007/s10147-017-1114-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
8 Chae EY, Shin HJ, Kim S, Baek HM, Yoon D, Kim S, Shim YE, Kim HH, Cha JH, Choi WJ, Lee JH, Shin JH, Lee HJ, Gong G. The Role of High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy for Predicting the Invasive Component in Patients with Ductal Carcinoma In Situ Diagnosed on Preoperative Biopsy. PLoS One 2016;11:e0161038. [PMID: 27560937 DOI: 10.1371/journal.pone.0161038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
9 Halabi S, Li C, Luo S. Developing and Validating Risk Assessment Models of Clinical Outcomes in Modern Oncology. JCO Precis Oncol 2019;3. [PMID: 31840130 DOI: 10.1200/PO.19.00068] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Wang L, Xia Y, Liu D, Zeng Y, Chang L, Li L, Hou Y, Ge L, Li W, Liu Z. Evaluating the efficacy of post-surgery adjuvant therapies used for ductal carcinoma in situ patients: a network meta-analysis. Oncotarget 2017;8:79257-69. [PMID: 29108304 DOI: 10.18632/oncotarget.17366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Rauch GM, Hobbs BP, Kuerer HM, Scoggins ME, Benveniste AP, Park YM, Caudle AS, Fox PS, Smith BD, Adrada BE, Krishnamurthy S, Yang WT. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence. Ann Surg Oncol 2016;23:482-9. [PMID: 26416712 DOI: 10.1245/s10434-015-4876-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
12 McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, Sneige N, Moughan J, Shah A, Germain I, Hartford AC, Rashtian A, Walker EM, Yuen A, Strom EA, Wilcox JL, Vallow LA, Small W Jr, Pu AT, Kerlin K, White J. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol 2015;33:709-15. [PMID: 25605856 DOI: 10.1200/JCO.2014.57.9029] [Cited by in Crossref: 231] [Cited by in F6Publishing: 72] [Article Influence: 33.0] [Reference Citation Analysis]
13 Van Zee KJ, Zabor EC, Di Donato R, Harmon B, Fox J, Morrow M, Cody HS 3rd, Fineberg SA. Comparison of Local Recurrence Risk Estimates After Breast-Conserving Surgery for DCIS: DCIS Nomogram Versus Refined Oncotype DX Breast DCIS Score. Ann Surg Oncol 2019;26:3282-8. [PMID: 31342373 DOI: 10.1245/s10434-019-07537-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
14 Ganly I, Amit M, Kou L, Palmer FL, Migliacci J, Katabi N, Yu C, Kattan MW, Binenbaum Y, Sharma K, Naomi R, Abib A, Miles B, Yang X, Lei D, Bjoerndal K, Godballe C, Mücke T, Wolff KD, Fliss D, Eckardt AM, Chiara C, Sesenna E, Ali S, Czerwonka L, Goldstein DP, Gil Z, Patel SG. Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study. Eur J Cancer 2015;51:2768-76. [PMID: 26602017 DOI: 10.1016/j.ejca.2015.09.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
15 Woodward WA, Sneige N, Winter K, Kuerer HM, Hudis C, Rakovitch E, Smith BL, Pierce LJ, Germano I, Pu AT, Walker EM, Grisell DL, White JR, McCormick B; Radiation Therapy Oncology Group (RTOG). Web based pathology assessment in RTOG 98-04. J Clin Pathol 2014;67:777-80. [PMID: 24989024 DOI: 10.1136/jclinpath-2014-202370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
16 Perry E, Talwar A, Taubman K, Ng M, Wong LM, Booth R, Sutherland TR. [18F]DCFPyL PET/CT in detection and localization of recurrent prostate cancer following prostatectomy including low PSA < 0.5 ng/mL. Eur J Nucl Med Mol Imaging 2021;48:2038-46. [PMID: 33399941 DOI: 10.1007/s00259-020-05143-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
17 Fang C, Wang W, Feng X, Sun J, Zhang Y, Zeng Y, Wang J, Chen H, Cai M, Lin J, Chen M, Chen Y, Li Y, Li S, Chen J, Zhou Z. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms. Br J Cancer 2017;117:1544-50. [PMID: 28949958 DOI: 10.1038/bjc.2017.315] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
18 Amornsiripanitch N, Lam DL, Rahbar H. Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ. Semin Roentgenol 2018;53:261-9. [PMID: 30449344 DOI: 10.1053/j.ro.2018.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Van Zee KJ, Subhedar P, Olcese C, Patil S, Morrow M. Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years. Ann Surg 2015;262:623-31. [PMID: 26366541 DOI: 10.1097/SLA.0000000000001454] [Cited by in Crossref: 72] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
20 Lui SA, Oh HB, Wang S, Chan CW. Ductal carcinoma in-situ arising within benign phyllodes tumours. Ann R Coll Surg Engl 2018;100:e97-e102. [PMID: 29484937 DOI: 10.1308/rcsann.2018.0024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Kim K, Jung SY, Shin KH, Kim JH, Han W, Lee HB, Huh SJ, Choi DH, Park W, Ahn SD, Kim SS, Kim JH, Suh CO, Kim YB, Kim IA, Kim S, Kim YJ. Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02). Breast Cancer Res Treat 2017;162:77-83. [PMID: 28083820 DOI: 10.1007/s10549-017-4111-1] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
22 Mittal K, Toss MS, Wei G, Kaur J, Choi DH, Melton BD, Osan RM, Miligy IM, Green AR, Janssen EAM, Søiland H, Gogineni K, Manne U, Rida P, Rakha EA, Aneja R. A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ. Clin Cancer Res 2020;26:2898-907. [PMID: 31937618 DOI: 10.1158/1078-0432.CCR-19-1272] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
23 Wai ES, Lesperance M, Lu L, Alexander CS, Truong PT. Effect of Referral Patterns and Treatment Type on Oncologic Outcomes for Women with Ductal Carcinoma In Situ. Cureus 2017;9:e1128. [PMID: 28465875 DOI: 10.7759/cureus.1128] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Leonard CE, Tole SP, Turner MP, Bennett JP, Howell KT, Carter DL. Association of the 12-Gene Breast DCIS Score® Assay With Local Recurrence in Patients With Ductal Carcinoma In Situ Treated on Accelerated Partial Breast Radiotherapy Protocols. Front Oncol 2021;11:671047. [PMID: 34221987 DOI: 10.3389/fonc.2021.671047] [Reference Citation Analysis]
25 Lambin P, van Stiphout RG, Starmans MH, Rios-Velazquez E, Nalbantov G, Aerts HJ, Roelofs E, van Elmpt W, Boutros PC, Granone P, Valentini V, Begg AC, De Ruysscher D, Dekker A. Predicting outcomes in radiation oncology--multifactorial decision support systems. Nat Rev Clin Oncol 2013;10:27-40. [PMID: 23165123 DOI: 10.1038/nrclinonc.2012.196] [Cited by in Crossref: 250] [Cited by in F6Publishing: 231] [Article Influence: 25.0] [Reference Citation Analysis]
26 Muhsen S, Barrio AV, Miller M, Olcese C, Patil S, Morrow M, Van Zee KJ. Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy. Ann Surg Oncol 2017;24:3888-95. [PMID: 28828599 DOI: 10.1245/s10434-017-6043-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
27 Leonard KL, Wazer DE. Genomic Assays and Individualized Treatment of Ductal Carcinoma In Situ in the Era of Value-Based Cancer Care. J Clin Oncol 2016;34:3953-5. [PMID: 29236596 DOI: 10.1200/JCO.2016.69.8332] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Cambra MJ, Moreno F, Sanz X, Anglada L, Mollà M, Reyes V, Arenas M, Pedro A, Ballester R, García V, Casals J, Cusidó M, Jimenez C, Escribà JM, Macià M, Solé JM, Arcusa A, Seguí MA, Gonzalez S, Farrús B, Biete A. Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients. Clin Transl Oncol 2020;22:670-80. [PMID: 31264148 DOI: 10.1007/s12094-019-02168-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Van Bockstal MR, Libbrecht L, Galant C. Comment on: "Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project". Br J Cancer 2021;124:1461-2. [PMID: 33589774 DOI: 10.1038/s41416-021-01280-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Pawloski KR, Tadros AB, Sevilimedu V, Newman A, Gentile L, Zabor EC, Morrow M, Van Zee KJ, Kirstein LJ. Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy. Breast Cancer Res Treat 2021;186:617-24. [PMID: 33675490 DOI: 10.1007/s10549-021-06129-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Warren LEG, Bellon JR. Should Everyone With Ductal Carcinoma in Situ Receive Adjuvant Radiation? J Clin Oncol 2021;39:3535-40. [PMID: 34613792 DOI: 10.1200/JCO.21.01896] [Reference Citation Analysis]
32 Guan YJ, Fang SY, Chen LL, Li ZD. Development and validation of prognostic nomograms for medullary thyroid cancer. Onco Targets Ther 2019;12:2299-309. [PMID: 30988634 DOI: 10.2147/OTT.S196205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Wang W, Sun Z, Deng JY, Qi XL, Feng XY, Fang C, Ma XH, Wang ZN, Liang H, Xu HM, Zhou ZW. A novel nomogram individually predicting disease-specific survival after D2 gastrectomy for advanced gastric cancer. Cancer Commun (Lond). 2018;38:23. [PMID: 29764518 DOI: 10.1186/s40880-018-0293-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
34 Ho AS, Wang L, Palmer FL, Yu C, Toset A, Patel S, Kattan MW, Tuttle RM, Ganly I. Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer. Ann Surg Oncol 2015;22:2700-6. [PMID: 25366585 DOI: 10.1245/s10434-014-4208-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
35 Mo H, Li P, Jiang S. A novel nomogram based on cardia invasion and chemotherapy to predict postoperative overall survival of gastric cancer patients. World J Surg Oncol 2021;19:256. [PMID: 34454511 DOI: 10.1186/s12957-021-02366-4] [Reference Citation Analysis]
36 Lei RY, Carter DL, Antell AG, Nowels MA, Tole SP, Bennett JP, Turner M, Baehner FL, Leonard CE. A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay. Adv Radiat Oncol 2021;6:100607. [PMID: 33912731 DOI: 10.1016/j.adro.2020.10.020] [Reference Citation Analysis]
37 Bennette CS, Ramsey SD, McDermott CL, Carlson JJ, Basu A, Veenstra DL. Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials. J Natl Cancer Inst 2016;108:djv324. [PMID: 26714555 DOI: 10.1093/jnci/djv324] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
38 Chen L, Yu S, Jiang X, Kang M. Supraclavicular lymph node metastasis in elderly patients undergoing esophageal squamous cell carcinoma radical surgery: construction of risk and prognostic predictive nomograms. J Thorac Dis 2021;13:18-30. [PMID: 33569181 DOI: 10.21037/jtd-20-1388] [Reference Citation Analysis]
39 Zhang DY, Huang GR, Ku JW, Zhao XK, Song X, Xu RH, Han WL, Zhou FY, Wang R, Wei MX, Wang LD. Development and validation of a prognostic nomogram model for Chinese patients with primary small cell carcinoma of the esophagus. World J Clin Cases 2021; 9(30): 9011-9022 [PMID: 34786384 DOI: 10.12998/wjcc.v9.i30.9011] [Reference Citation Analysis]
40 Pilewskie M, Olcese C, Patil S, Van Zee KJ. Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy? Ann Surg Oncol 2016;23:4253-61. [PMID: 27766556 DOI: 10.1245/s10434-016-5595-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
41 Pilewskie M, Olcese C, Eaton A, Patil S, Morris E, Morrow M, Van Zee KJ. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation. Ann Surg Oncol 2014;21:1552-60. [PMID: 24385207 DOI: 10.1245/s10434-013-3424-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
42 Mamtani A, Van Zee KJ. ASO Author Reflections: Advising a Woman with Ductal Carcinoma In Situ Regarding Various Treatment Options-A Complex Decision. Ann Surg Oncol 2019;26:4272-3. [PMID: 31549321 DOI: 10.1245/s10434-019-07859-x] [Reference Citation Analysis]
43 Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HM. Biology, treatment, and outcome in very young and older women with DCIS. Ann Surg Oncol 2012;19:3777-84. [PMID: 22622473 DOI: 10.1245/s10434-012-2413-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 5.2] [Reference Citation Analysis]
44 Shachar SS, Muss HB. Internet tools to enhance breast cancer care. NPJ Breast Cancer 2016;2:16011. [PMID: 28721377 DOI: 10.1038/npjbcancer.2016.11] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
45 Shehata M, Grimm L, Ballantyne N, Lourenco A, Demello LR, Kilgore MR, Rahbar H. Ductal Carcinoma in Situ: Current Concepts in Biology, Imaging, and Treatment. J Breast Imaging 2019;1:166-76. [PMID: 31538141 DOI: 10.1093/jbi/wbz039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
46 Tong D, Tian Y, Zhou T, Ye Q, Li J, Ding K, Li J. Improving prediction performance of colon cancer prognosis based on the integration of clinical and multi-omics data. BMC Med Inform Decis Mak 2020;20:22. [PMID: 32033604 DOI: 10.1186/s12911-020-1043-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Farolfi A, Petracci E, Serra L, Ravaioli A, Bravaccini S, Ravaioli S, Tumedei MM, Ulivi P, Canale M, Puccetti M, Falcini F, Folli S, Curcio A, Rocca A. Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ. Front Oncol 2020;10:1486. [PMID: 32974178 DOI: 10.3389/fonc.2020.01486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S, Hunt KK. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 2012;30:600-7. [PMID: 22253459 DOI: 10.1200/JCO.2011.36.4976] [Cited by in Crossref: 85] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
49 Choi DX, Van Zee KJ. Memorial sloan-kettering cancer center: two decades of experience with ductal carcinoma in situ of the breast. Int J Surg Oncol 2012;2012:723916. [PMID: 22685640 DOI: 10.1155/2012/723916] [Reference Citation Analysis]
50 Albert JM, Liu DD, Shen Y, Pan IW, Shih YC, Hoffman KE, Buchholz TA, Giordano SH, Smith BD. Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery. J Clin Oncol 2012;30:2837-43. [PMID: 22734034 DOI: 10.1200/JCO.2011.41.0076] [Cited by in Crossref: 49] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
51 Gao Z, Ni J, Ding H, Yan C, Ren C, Li G, Pan F, Jin G. A nomogram for prediction of stage III/IV gastric cancer outcome after surgery: A multicenter population-based study. Cancer Med 2020;9:5490-9. [PMID: 32543092 DOI: 10.1002/cam4.3215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
52 Wright JL, Rahbar H, Obeng-Gyasi S, Carlos R, Tjoe J, Wolff AC. Overcoming Barriers in Ductal Carcinoma In Situ Management: From Overtreatment to Optimal Treatment. J Clin Oncol 2021;:JCO2101674. [PMID: 34813345 DOI: 10.1200/JCO.21.01674] [Reference Citation Analysis]
53 Shurell E, Olcese C, Patil S, McCormick B, Van Zee KJ, Pilewskie ML. Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situ. Cancer 2018;124:46-54. [PMID: 28960259 DOI: 10.1002/cncr.30972] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
54 Klimov S, Miligy IM, Gertych A, Jiang Y, Toss MS, Rida P, Ellis IO, Green A, Krishnamurti U, Rakha EA, Aneja R. A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk. Breast Cancer Res 2019;21:83. [PMID: 31358020 DOI: 10.1186/s13058-019-1165-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
55 Hwang ES, Solin L. De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer. J Clin Oncol 2020;38:2230-9. [PMID: 32442066 DOI: 10.1200/JCO.19.02888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
56 Cronin PA, Olcese C, Patil S, Morrow M, Van Zee KJ. Impact of Age on Risk of Recurrence of Ductal Carcinoma In Situ: Outcomes of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years. Ann Surg Oncol 2016;23:2816-24. [PMID: 27198513 DOI: 10.1245/s10434-016-5249-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
57 Subhedar P, Olcese C, Patil S, Morrow M, Van Zee KJ. Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years. Ann Surg Oncol 2015;22:3273-81. [PMID: 26215193 DOI: 10.1245/s10434-015-4740-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
58 Chen D, Jiang B, Xing J, Liu M, Cui M, Liu Y, Wang Z, Chen L, Yang H, Zhang C, Yao Z, Zhang N, Ji J, Qu H, Su X. Validation of the memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after R0 resection in a Chinese gastric cancer population. PLoS One 2013;8:e76041. [PMID: 24146811 DOI: 10.1371/journal.pone.0076041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
59 Yang L, Lu D, Lai Y, Shen M, Yu Q, Lei T, Pu T, Bu H. Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels. Ann Surg Oncol 2021;28:975-84. [PMID: 32794031 DOI: 10.1245/s10434-020-09003-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 Jelovsek JE, Chagin K, Brubaker L, Rogers RG, Richter HE, Arya L, Barber MD, Shepherd JP, Nolen TL, Norton P, Sung V, Menefee S, Siddiqui N, Meikle SF, Kattan MW; Pelvic Floor Disorders Network. A model for predicting the risk of de novo stress urinary incontinence in women undergoing pelvic organ prolapse surgery. Obstet Gynecol 2014;123:279-87. [PMID: 24402598 DOI: 10.1097/AOG.0000000000000094] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
61 Lischka A, Doberstein N, Freitag-Wolf S, Koçak A, Gemoll T, Heselmeyer-Haddad K, Ried T, Auer G, Habermann JK. Genome Instability Profiles Predict Disease Outcome in a Cohort of 4,003 Patients with Breast Cancer. Clin Cancer Res 2020;26:4606-15. [PMID: 32522886 DOI: 10.1158/1078-0432.CCR-20-0566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Su D, Zhou X, Chen Q, Jiang Y, Yang X, Zheng W, Tao K, Wu J, Yan Z, Liu L, Wu S, Mao W. Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy. PLoS One 2015;10:e0124437. [PMID: 25893524 DOI: 10.1371/journal.pone.0124437] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
63 Pearson SJ, Roy Sarkar T, McQueen CM, Elswood J, Schmitt EE, Wall SW, Scribner KC, Wyatt G, Barhoumi R, Behbod F, Rijnkels M, Porter WW. ATM-dependent activation of SIM2s regulates homologous recombination and epithelial-mesenchymal transition. Oncogene 2019;38:2611-26. [PMID: 30531838 DOI: 10.1038/s41388-018-0622-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
64 Punglia RS, Burstein HJ, Weeks JC. Radiation therapy for ductal carcinoma in situ: a decision analysis. Cancer 2012;118:603-11. [PMID: 21720992 DOI: 10.1002/cncr.26293] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
65 Mamtani A, Van Zee KJ. Treatment of Ductal Carcinoma in Situ: Considerations for Tailoring Therapy in the Contemporary Era. Curr Breast Cancer Rep 2020;12:98-106. [PMID: 33552389 DOI: 10.1007/s12609-020-00360-5] [Reference Citation Analysis]
66 Van Bockstal MR, Agahozo MC, Koppert LB, van Deurzen CHM. A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast. Int J Cancer 2020;146:1189-97. [PMID: 31018242 DOI: 10.1002/ijc.32362] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
67 Lazzeroni M, Guerrieri-Gonzaga A, Botteri E, Leonardi MC, Rotmensz N, Serrano D, Varricchio C, Disalvatore D, Del Castillo A, Bassi F, Pagani G, DeCensi A, Viale G, Bonanni B, Pruneri G. Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype. Br J Cancer 2013;108:1593-601. [PMID: 23579208 DOI: 10.1038/bjc.2013.147] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
68 Parikh P, Pockaj B, Wasif N, Halyard M, Wong W, Kosiorek HE, Dueck AC, Gray R. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast. Ann Surg Oncol 2015;22 Suppl 3:S516-21. [PMID: 25986869 DOI: 10.1245/s10434-015-4607-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
69 Badve SS, Gökmen-Polar Y. Ductal carcinoma in situ of breast: update 2019. Pathology 2019;51:563-9. [PMID: 31472981 DOI: 10.1016/j.pathol.2019.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
70 Punglia RS, Bifolck K, Golshan M, Lehman C, Collins L, Polyak K, Mittendorf E, Garber J, Hwang SE, Schnitt SJ, Partridge AH, King TA. Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). JNCI Cancer Spectr 2018;2:pky063. [PMID: 30627695 DOI: 10.1093/jncics/pky063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
71 Shah C, Vicini FA, Berry S, Julian TB, Wilkinson JB, Shaitelman SF, Khan A, Finkelstein SE, Goldstein N. Ductal Carcinoma In Situ of the Breast: Evaluating the Role of Radiation Therapy in the Management and Attempts to Identify Low-risk Patients. Am J Clin Oncol 2015;38:526-33. [PMID: 25036472 DOI: 10.1097/COC.0000000000000102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
72 Shikama N, Sekiguchi K, Nakamura N, Sekine H, Nakayama Y, Imanaka K, Akiba T, Aoki M, Hatayama Y, Ogo E, Kagami Y, Kawashima M, Karasawa K. Final results from a multicenter prospective study ( JROSG 05-5) on postoperative radiotherapy for patients with ductal carcinoma in situ with an involved surgical margin or close margin widths of 1 mm or less. J Radiat Res 2015;56:830-4. [PMID: 26093369 DOI: 10.1093/jrr/rrv034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
73 Jiang WD, Yuan PC. Development and validation of prognostic nomograms for patients with metastatic prostate cancer. Int Urol Nephrol 2019;51:1743-53. [PMID: 31289983 DOI: 10.1007/s11255-019-02224-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
74 Stuart KE, Houssami N, Taylor R, Hayen A, Boyages J. Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis. BMC Cancer 2015;15:890. [PMID: 26555555 DOI: 10.1186/s12885-015-1904-7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 6.9] [Reference Citation Analysis]
75 Wood WC. Ductal Carcinoma In Situ of the Breast: Should Breast Irradiation Be Routinely Added to Surgical Excision? J Oncol Pract 2016;12:309-11. [PMID: 27072386 DOI: 10.1200/JOP.2015.010488] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
76 Rahbar H, McDonald ES, Lee JM, Partridge SC, Lee CI. How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis? Acad Radiol 2016;23:768-73. [PMID: 27017136 DOI: 10.1016/j.acra.2016.02.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
77 Choi DX, Eaton AA, Olcese C, Patil S, Morrow M, Van Zee KJ. Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer? Ann Surg Oncol 2013;20:1302-10. [PMID: 23161115 DOI: 10.1245/s10434-012-2719-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
78 Hassett MJ, Jiang W, Habel LA, Nekhlyudov L, Achacoso N, Acton L, Schnitt SJ, Schrag D, Punglia RS. Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community. Breast Cancer Res Treat 2016;155:541-9. [PMID: 26843057 DOI: 10.1007/s10549-016-3692-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
79 Orsaria P, Granai AV, Venditti D, Petrella G, Buonomo O. Investigational Paradigms in Downscoring and Upscoring DCIS: Surgical Management Review. Int J Surg Oncol 2012;2012:560493. [PMID: 22666571 DOI: 10.1155/2012/560493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
80 Gorringe KL, Fox SB. Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis. Front Oncol 2017;7:248. [PMID: 29109942 DOI: 10.3389/fonc.2017.00248] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 10.2] [Reference Citation Analysis]
81 Zhang WY, Chen XX, Chen WH, Zhang H, Zou CL. Nomograms for predicting risk of locoregional recurrence and distant metastases for esophageal cancer patients after radical esophagectomy. BMC Cancer 2018;18:879. [PMID: 30200913 DOI: 10.1186/s12885-018-4796-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
82 Wang Y, Yang Y, Chen Z, Zhu T, Wu J, Su F, Deng H. Development and validation of a novel nomogram for predicting distant metastasis-free survival among breast cancer patients. Ann Transl Med 2019;7:537. [PMID: 31807519 DOI: 10.21037/atm.2019.10.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
83 McCormick B. It is time to personalize local treatment options for women with "good risk" DCIS. Breast J 2018;24:231-2. [PMID: 29870127 DOI: 10.1111/tbj.12890] [Reference Citation Analysis]
84 Solin LJ. Management of Ductal Carcinoma In Situ (DCIS) of the Breast: Present Approaches and Future Directions. Curr Oncol Rep 2019;21:33. [PMID: 30834994 DOI: 10.1007/s11912-019-0777-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
85 Lee DY, Lewis JL, Wexelman BA, Freedman BC, Ross RE, Tartter PI. The consequence of undertreatment of patients treated with breast conserving therapy for ductal carcinoma in-situ. Am J Surg 2013;206:790-7. [PMID: 23866765 DOI: 10.1016/j.amjsurg.2013.03.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
86 Scaranelo AM, Lord B, Eiada R, Hofer SO. Imaging approaches and findings in the reconstructed breast: a pictorial essay. Can Assoc Radiol J 2011;62:60-72. [PMID: 21067890 DOI: 10.1016/j.carj.2010.09.010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Farante G, Toesca A, Magnoni F, Lissidini G, Vila J, Mastropasqua M, Viale G, Penco S, Cassano E, Lazzeroni M, Bonanni B, Leonardi MC, Ripoll-Orts F, Curigliano G, Orecchia R, Galimberti V, Veronesi P. Advances and controversies in management of breast ductal carcinoma in situ (DCIS). Eur J Surg Oncol 2021:S0748-7983(21)00780-0. [PMID: 34772587 DOI: 10.1016/j.ejso.2021.10.030] [Reference Citation Analysis]
88 Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol 2015;16:e173-80. [PMID: 25846097 DOI: 10.1016/S1470-2045(14)71116-7] [Cited by in Crossref: 678] [Cited by in F6Publishing: 503] [Article Influence: 96.9] [Reference Citation Analysis]